Sleep-specific outcomes attributable to digitally delivered cognitive behavioral therapy for insomnia in adults with insomnia and depressive symptoms.

Autor: Batterham PJ; Centre for Mental Health Research, College of Health and Medicine, The Australian National University, Canberra, Australia., Thorndike FP; Center for Behavioral Health and Technology, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA.; Nox Health, Alpharetta, GA, USA., Gerwien R; Pear Therapeutics, Boston, MA, USA., Botbyl J; Provonix, Sewell, NJ, USA., Ritterband LM; Center for Behavioral Health and Technology, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA., Maricich Y; Pear Therapeutics, Boston, MA, USA., Christensen H; Black Dog Institute, The University of New South Wales, Sydney, NSW, Australia.
Jazyk: angličtina
Zdroj: Behavioral sleep medicine [Behav Sleep Med] 2024 Jul-Aug; Vol. 22 (4), pp. 410-419. Date of Electronic Publication: 2023 Nov 28.
DOI: 10.1080/15402002.2023.2285799
Abstrakt: Objective: Randomized controlled trials (RCTs) of digitally delivered Cognitive Behavioral Therapy for insomnia (CBT-I) have demonstrated reductions in insomnia severity, depression symptoms, anxiety symptoms, and suicidal ideation. The present study aimed to evaluate the effectiveness of self-guided, digital CBT-I to improve sleep-specific outcomes.
Method: An RCT of Australian adults with insomnia and depressive symptoms ( N  = 1149) compared SHUTi, a digital CBT-I intervention, with HealthWatch, an attention-matched control internet program, at baseline, posttest (9 weeks) and at 6-, 12-, and 18-month follow-ups. Online sleep diaries were used to derive measures of sleep-onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE), number of awakenings, sleep quality, and total sleep time (TST).
Results: Participants in the SHUTi condition had greater improvements at posttest compared with control for: SOL, WASO, SE, number of awakenings, and sleep quality. These improvements were sustained at every follow-up ( p  < .02 for all outcomes except TST, in which statistically significant increases were observed only at 12- and 18-months).
Conclusions: Digitally delivered CBT-I produced lasting improvements in sleep outcomes among adults with insomnia and depressive symptoms. Findings provide further evidence of long-term improvements associated with a digital therapeutic for insomnia, compared to an attention-control condition.
Databáze: MEDLINE